Stephen A. Rowe
University of Michigan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen A. Rowe.
Annals of Surgery | 2004
Mark R. Hemmila; Stephen A. Rowe; Tamer N. Boules; Judiann Miskulin; John W. McGillicuddy; Douglas J. Schuerer; Jonathan W. Haft; Fresca Swaniker; Saman Arbabi; Ronald B. Hirschl; Robert H. Bartlett
Objective:Severe acute respiratory distress syndrome (ARDS) is associated with a high level of mortality. Extracorporeal life support (ECLS) during severe ARDS maintains oxygen and carbon dioxide gas exchange while providing an optimal environment for recovery of pulmonary function. Since 1989, we have used a protocol-driven algorithm for treatment of severe ARDS, which includes the use of ECLS when standard therapy fails. The objective of this study was to evaluate our experience with ECLS in adult patients with severe ARDS with respect to mortality and morbidity. Methods:We reviewed our complete experience with ELCS in adults from January 1, 1989, through December 31, 2003. Severe ARDS was defined as acute onset pulmonary failure, with bilateral infiltrates on chest x-ray, and PaO2/fraction of inspired oxygen (FiO2) ratio ≤100 or A-aDO2 >600 mm Hg despite maximal ventilator settings. The indication for ECLS was acute severe ARDS unresponsive to optimal conventional treatment. The technique of ECLS included veno-venous or veno-arterial vascular access, lung “rest” at low FiO2 and inspiratory pressure, minimal anticoagulation, and optimization of systemic oxygen delivery. Results:During the study period, ECLS was used for 405 adult patients age 17 or older. Of these 405 patients, 255 were placed on ECLS for severe ARDS refractory to all other treatment. Sixty-seven percent were weaned off ECLS, and 52% survived to hospital discharge. Multivariate logistic regression analysis identified the following pre-ELCS variables as significant independent predictors of survival: (1) age (P = 0.01); (2) gender (P = 0.048); (3) pH ≤7.10 (P = 0.01); (4) PaO2/FiO2 ratio (P = 0.03); and (5) days of mechanical ventilation (P < 0.001). None of the patients who survived required permanent mechanical ventilation or supplemental oxygen therapy. Conclusion:Extracorporeal life support for severe ARDS in adults is a successful therapeutic option in those patients who do not respond to conventional mechanical ventilator strategies.
Journal of Trauma-injury Infection and Critical Care | 2005
Joseph F. Magliocca; John C. Magee; Stephen A. Rowe; Mark T. Gravel; Richard Chenault; Robert M. Merion; Jeffrey Punch; Robert H. Bartlett; Mark R. Hemmila
Background:We sought to evaluate the effect on short-term outcomes of normothermic, extracorporeal perfusion (ECMO) for donation of abdominal organs for transplantation after cardiac death (DCD). Study parameters included increase in number of donors and organs, types of organs procured, and viabili
Journal of Trauma-injury Infection and Critical Care | 2004
Mark R. Hemmila; Saman Arbabi; Stephen A. Rowe; Mary Margaret Brandt; Stewart C. Wang; Paul A. Taheri; Wendy L. Wahl; Kenneth L. Mattox; Steven E. Ross; Steven R. Shackford; Carol R. Schermer; Tetsu Yukioka; Mary C. McCarthy; J. David Richardson; Timothy C. Fabian
BACKGROUND Blunt thoracic aortic injury (BTAI) is a severe injury that traditionally has mandated immediate surgical repair. Delaying operative intervention for BTAI can allow other life-threatening injuries to be managed first, but potentially increases the risk of aortic rupture and death. The objective of this study was to evaluate the outcome of delayed repair (DR) compared with early repair (ER) for BTAI and to assess the effectiveness of a protocol for medical control of systolic blood pressure and heart rate in those patients whose repairs were delayed. METHODS This study is a retrospective review of University of Michigan Health System (UMHS) data from January 1, 1992, through March 1, 2003. ER was defined as operative repair within 16 hours from the time of injury. A similar analysis was conducted for patients with BTAI selected from the National Trauma Data Bank. RESULTS For the UMHS data, there were 45 patients in the DR group and 33 patients in the ER group. Mortality in the ER group versus the DR group was 9% versus 20%. Multivariate analysis adjusting for age, Injury Severity Score, abdominal Abbreviated Injury Scale score, Glasgow Coma Scale score, and intubation status demonstrated an odds ratio for death from ER compared with DR of 1.72 (p = 0.57). Patients undergoing DR had an absolute increase in hospital length of stay (33.1 vs. 20.9 days) and complication rate (2.1 vs. 1.5 incidents per patient). A similar result was obtained for multivariate analysis of the National Trauma Data Bank data, with an odds ratio of 1.40 (p = 0.51) for death from ER versus DR. UMHS patients whose repairs were delayed achieved target systolic blood pressure and heart rate for 76% and 74% of the hourly measurements recorded, respectively. CONCLUSION Patients with BTAI can safely undergo delayed aortic repair if other injuries warrant a higher treatment priority without increasing their overall risk of mortality. Delayed repair is, however, associated with a higher complication rate.
Journal of Burn Care & Rehabilitation | 2005
Wendy L. Wahl; Karla S. Ahrns; Mary Margaret Brandt; Stephen A. Rowe; Mark R. Hemmila; Saman Arbabi
Ventilator-associated pneumonia (VAP) remains a major cause of morbidity and mortality for patients with burns. In nonburn populations, bronchoalveolar lavage (BAL) excludes other pathology such as systemic inflammatory response syndrome. We hypothesized that BAL would decrease our false-positive VAP rate. All ventilated patients with burn injury who were admitted to our institution from July 2000 through June 2003 were included. After June 2001, BAL was used to make the diagnosis of VAP, with > or =10(4) organisms considered a positive result. Fifty patients met criteria for VAP, 21 in the pre-BAL period and 29 in the BAL period. Six patients (21%) in the BAL group had quantitative cultures <10(4) and were not treated. The outcomes for these patients were not different than those treated for VAP. There were no differences in age, TBSA size, antibiotic use, or ventilator days for the pre-BAL or BAL groups, although the pneumonia rate was lower for the BAL time period. The use of BAL eliminated the unnecessary antibiotic treatment of 21% of patients in the BAL time period and was associated with a lower rate of VAP.
Surgery | 2004
Wendy L. Wahl; Karla S. Ahrns; Steven L. Chen; Mark R. Hemmila; Stephen A. Rowe; Saman Arbabi
Association for the Advancement of Automotive Medicine 47th Annual ConferenceAssociation for the Advancement of Automotive Medicine (AAAM) | 2003
Stewart C. Wang; Brian Bednarski; Smita Patel; Alice Yan; Carla Kohoyda-Inglis; Theresa Kennedy; Elizabeth Link; Stephen A. Rowe; Mark R. Sochor; Saman Arbabi
Surgery | 2004
Stephen A. Rowe; Mark S. Sochor; Kurtis S. Staples; Wendy L. Wahl; Stewart C. Wang
Association for the Advancement of Automotive Medicine 48th Annual ConferenceAssociation for the Advancement of Automotive Medicine (AAAM) | 2004
Stewart C. Wang; Chris Brede; David C. Lange; Craig S. Poster; Aaron W. Lange; Carla Kohoyda-Inglis; Mark R. Sochor; Kyros Ipaktchi; Stephen A. Rowe; Smita Patel; Hugh J. L. Garton
Journal of Surgical Research | 2004
Stephen A. Rowe; Saman Arbabi; Mark R. Hemmila; Paul A. Taheri; Stewart C. Wang; Wendy L. Wahl; Mary-Margaret Brandt
Chest | 2004
Robert H. Bartlett; Mark R. Hemmila; Fresca Swaniker; Jonathan W. Haft; Ronald B. Hirschl; Stephen A. Rowe